Compare PLX & BOOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLX | BOOM |
|---|---|---|
| Founded | 1993 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.9M | 124.4M |
| IPO Year | 1998 | N/A |
| Metric | PLX | BOOM |
|---|---|---|
| Price | $1.82 | $6.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | $8.50 |
| AVG Volume (30 Days) | ★ 509.8K | 189.5K |
| Earning Date | 11-13-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | $61,840,000.00 | ★ $618,683,000.00 |
| Revenue This Year | $14.29 | N/A |
| Revenue Next Year | $16.65 | $1.52 |
| P/E Ratio | $26.64 | ★ N/A |
| Revenue Growth | ★ 35.41 | N/A |
| 52 Week Low | $1.32 | $5.46 |
| 52 Week High | $3.10 | $9.92 |
| Indicator | PLX | BOOM |
|---|---|---|
| Relative Strength Index (RSI) | 44.81 | 53.88 |
| Support Level | $1.68 | $6.16 |
| Resistance Level | $1.78 | $6.85 |
| Average True Range (ATR) | 0.09 | 0.29 |
| MACD | 0.02 | 0.15 |
| Stochastic Oscillator | 78.57 | 84.62 |
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.